B. Hauns

The pharmacokinetics of a 1-h paclitaxel infusion

K. Mross, N. Holl�nder, B. Hauns et al. · Cancer Chemotherapy and Pharmacology · 2000 · 54 citations

Medicine, Pharmacokinetics, Pharmacology +9

Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics.

H. Maier-Lenz, B. Hauns, B Haering et al. · PubMed · 1997 · 33 citations

Medicine, Pharmacokinetics, Pharmacology +11

Phase II Study of Combined 5-Fluorouracil/Ginkgo biloba Extract (GBE 761 ONC) Therapy in 5-Fluorouracil Pretreated Patients with Advanced Colorectal Cancer

B. Hauns, B. H�ring, S. K�hler et al. · Phytotherapy Research · 2001 · 28 citations

Medicine, Oncology, Pharmacology +11

Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects

T.D. Bethke, Kristin Westphal, Andrea Weinbrenner et al. · International Journal of Clinical Pharmacology and Therapeutics · 2006 · 21 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Clinical phase I study with one-hour paclitaxel infusion

K. Mross, B. Hauns, B. Häring et al. · Annals of Oncology · 1998 · 15 citations

Pharmacy, Pharmacokinetics, Pharmacology +13